<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-188 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-188</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-188</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-10.html">extraction-schema-10</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <p><strong>Paper ID:</strong> paper-ab7154682779116f83921008d3707796d2fc1c23</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/ab7154682779116f83921008d3707796d2fc1c23" target="_blank">Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</a></p>
                <p><strong>Paper Venue:</strong> Cureus</p>
                <p><strong>Paper TL;DR:</strong> A 35-year-old healthy male, initially thought to have drug-induced liver injury, who was subsequently diagnosed with thymoma-induced autoimmune hepatitis is presented, a rare syndrome of which only two previous cases have been reported.</p>
                <p><strong>Paper Abstract:</strong> Thymomas are rare neoplasms of the thymus and are often associated with immune-mediated paraneoplastic syndromes, most commonly, myasthenia gravis. The same underlying mechanism can produce antibodies to other self-antigens in various organ systems. Autoimmune hepatitis is a rare complication of thymoma. We present a 35-year-old healthy male, initially thought to have drug-induced liver injury, who was subsequently diagnosed with thymoma-induced autoimmune hepatitis, a rare syndrome of which only two previous cases have been reported.</p>
                <p><strong>Cost:</strong> 0.015</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e188.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e188.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>AIH</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Autoimmune hepatitis</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>An immune-mediated inflammation of the liver reported as a rare paraneoplastic syndrome of thymoma; histology shows lymphocytic interface hepatitis with plasma cells and elevated IgG, and it may present simultaneously with, before, or after thymoma diagnosis.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Autoimmune hepatitis</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>Rare; in one series of 85 thymoma patients 1 had autoimmune hepatitis (~1.2%); fewer than 10 published case reports historically (paper cites 9 prior cases in literature review)</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Failure of central tolerance due to thymoma-mediated disruption of negative selection (three hypotheses cited: 1) 'escape' of immature T cells from a disorganized neoplastic thymic environment before negative selection, 2) dysplastic/genetic defects in neoplastic thymic epithelial cells impairing negative selection, and 3) mutation or dysfunction of the AIRE gene involved in negative selection), resulting in export of autoreactive T-lymphocytes that target hepatic self-antigens.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Patient-level: elevated IgG, weakly positive ANA (1:40, speckled), weakly positive anti-smooth muscle antibody (ASMA 1:40); histology: predominant lymphocytic interface hepatitis with occasional plasma cells and (initially) cholestasis; literature-level: persistence of peripheral autoreactive T cells exported from thymoma and reports of mature long-lived CD4+ and CD8+ T cells generated by thymoma (cited).</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td>Weakly positive ANA (1:40, speckled) and anti-smooth muscle antibody (ASMA 1:40) reported in the case; elevated serum IgG (1663 mg/dL).</td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>Variable: literature review in paper reports 7/9 historical cases diagnosed simultaneously with thymoma, 1 developed AIH a few months after thymoma diagnosis, and 1 developed AIH four years after diagnosis; the case reported had liver enzyme abnormalities detected before thymoma diagnosis and AIH features recurring after thymectomy/chemotherapy.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td>Not consistently curative for non-myasthenic paraneoplastic autoimmune disorders; exported autoreactive T cells can persist in the periphery and cause delayed appearance or persistence of disease. In this case liver-associated enzymes normalized after resection and chemotherapy but biochemical relapse occurred months later after completion of therapy and steroid withdrawal.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td>Literature review: patients with thymoma-associated AIH tended to be young (mean age ~32 years) and five of nine reported cases were of Asian descent (possible genetic predisposition); many had additional autoimmune disorders (7/9 had other autoimmune diseases).</td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>Described conceptually: thymic disorganization allowing immature T cells to escape negative selection; possible dysplastic genetic defects in neoplastic thymic epithelial cells; potential AIRE gene mutation/dysfunction (theories discussed, not measured in this case).</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td>Paper cites that thymomas can generate mature, long-lived CD4+ and CD8+ T cells and that autoreactive T-lymphocytes exported from the thymoma can persist for months to years in the periphery; no specific T-cell clonality or repertoire data provided for AIH cases in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e188.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>MG</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Myasthenia gravis</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The most commonly associated paraneoplastic autoimmune disease with thymoma, characterized by antibodies impairing neuromuscular transmission; cited as the prototypical thymoma-associated autoimmune syndrome.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Myasthenia gravis</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>Approximately 50% of thymoma patients (paper cites myasthenia gravis affects 50% of thymoma patients).</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Impaired central tolerance by the thymoma leading to export of autoreactive T cells that help drive autoantibody formation against neuromuscular antigens; same general mechanisms as other thymoma-associated autoimmunity (escape of immature T cells, genetic defects, possible AIRE dysfunction).</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>Paper references generation by thymoma of mature, long-lived CD4+ and CD8+ T cells (cited study) and the role of exported T-cells in initiating autoantibody responses; no new serologic data in this paper's case (the presented patient tested negative for myasthenia gravis).</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>Often coincides with thymoma diagnosis but timing can vary; paraneoplastic syndromes may precede, coincide with, or follow thymoma diagnosis (general statement).</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td>Not explicitly quantified in paper for MG, but paper notes that outside myasthenia gravis thymectomy has not been shown to consistently resolve paraneoplastic autoimmune disorders; implication is that exported autoreactive T cells may persist despite thymectomy. (Specific MG outcomes not detailed in this paper.)</td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>General thymic disorganization impairing negative selection is described as the mechanism leading to MG in thymoma patients; AIRE-related or genetic defects mentioned as possible causes.</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td>Reference to production of mature, long-lived CD4+ and CD8+ T cells by thymoma (cited literature), supporting a role for T cells in MG pathogenesis in thymoma patients.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e188.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Autoimmune disease (any)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Autoimmune disease associated with thymoma (aggregate)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Thymomas are frequently associated with a range of autoimmune/paraneoplastic syndromes; in a cited series more than half of patients presented with an autoimmune disease.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Autoimmune disease (aggregate, multiple types)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td>In one cited series of 85 thymoma patients, 55% presented with an autoimmune disease.</td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>General failure of thymic negative selection and export of autoreactive T cells (escape theory, genetic dysplasia of neoplastic thymic epithelium, possible AIRE dysfunction), leading to humoral and/or cellular loss of tolerance and cross-reactivity to peripheral self-antigens.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td>General conceptually described findings: export and peripheral persistence of autoreactive T-lymphocytes; cited literature reporting thymoma-produced mature CD4+ and CD8+ T cells and involvement of T-cells in initiation of autoantibody responses.</td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td>Variable â€” paraneoplastic autoimmune syndromes often manifest concurrently with thymoma diagnosis but can precede discovery or appear later, even after thymoma resection.</td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td>Thymectomy may not reliably resolve non-myasthenic paraneoplastic autoimmune disorders because autoreactive T cells may already have been exported to the periphery prior to resection.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td>Described generally as neoplastic disorganization of thymic architecture impairing negative selection; possible AIRE involvement and genetic dysplasia discussed.</td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td>Export of mature autoreactive T cells that can persist in the periphery for months to years; no quantitative T-cell subset data provided in this paper for the aggregate group.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e188.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Polymyositis</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Polymyositis</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>An inflammatory myopathy listed among autoimmune syndromes reported in association with thymoma in the literature review; two of nine historical thymoma-associated AIH cases had concomitant polymyositis.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Polymyositis</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Impaired thymic negative selection and export of autoreactive T cells from thymoma (general mechanism described for thymoma-associated autoimmunity).</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e188.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Autoimmune thyroid disease</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Autoimmune thyroid diseases (Graves' disease, Hashimoto's thyroiditis)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Autoimmune thyroid disorders (both Graves' disease and Hashimoto's thyroiditis) are cited as possible paraneoplastic syndromes associated with thymoma.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Graves' disease and Hashimoto's thyroiditis</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>General thymoma-associated failure of central tolerance leading to autoreactive T cells and humoral autoimmunity affecting the thyroid.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e188.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Neuromyotonia and other neuro-autoimmune</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Neuromyotonia (and other nervous system paraneoplastic syndromes)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Nervous-system autoimmune/paraneoplastic syndromes, including neuromyotonia, psychosis, and polymyositis, are reported as relatively common thymoma-associated autoimmune manifestations.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Neuromyotonia (and other nervous system paraneoplastic syndromes)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Export of autoreactive T cells from thymoma with cross-reactivity to neuronal antigens; impaired negative selection is implicated generally.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e188.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Dermatologic autoimmune</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Cutaneous autoimmune syndromes (pemphigus, vitiligo)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Cutaneous autoimmune conditions such as pemphigus and vitiligo are listed as paraneoplastic syndromes seen with thymoma.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Pemphigus; vitiligo</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>General loss of central tolerance with peripheral autoimmunity secondary to thymoma-related defects in negative selection/export of autoreactive T cells.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e188.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>SLE</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Systemic lupus erythematosus</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Systemic lupus erythematosus is mentioned among non-neurologic autoimmune/paraneoplastic syndromes reported with thymoma.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Systemic lupus erythematosus (SLE)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>General thymoma-associated impairment of negative selection causing peripheral autoreactivity and autoantibody production.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.8">
                <h3 class="extraction-instance">Extracted Data Instance 8 (e188.8)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>GN</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Glomerulonephritis</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Glomerulonephritis is listed as one of the organ-system autoimmune/paraneoplastic conditions reported in association with thymoma.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Glomerulonephritis</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>General failure of thymic negative selection leading to peripheral autoimmunity (as described for thymoma-associated syndromes).</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.9">
                <h3 class="extraction-instance">Extracted Data Instance 9 (e188.9)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Hematologic aplasias</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Hematologic aplasias (e.g., pure red cell aplasia and other aplasias)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Hematologic aplasias are reported in the literature as autoimmune/paraneoplastic phenomena associated with thymoma.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Hematologic aplasias (e.g., aplastic processes)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Exported autoreactive T cells and loss of tolerance due to disrupted thymic negative selection.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e188.10">
                <h3 class="extraction-instance">Extracted Data Instance 10 (e188.10)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of autoimmune diseases in thymoma patients, including prevalence rates, proposed mechanisms, immunological findings, and clinical characteristics that explain the connection between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Diabetes (autoimmune)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Diabetes mellitus (reported as autoimmune in some thymoma cases)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Diabetes mellitus was reported in the literature review as co-occurring with thymoma-associated autoimmune hepatitis in one case (presumed to be autoimmune/type 1 in the context).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Diabetes mellitus (reported concomitantly in one case)</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_prevalence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymoma_type</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>General thymoma-associated loss of central tolerance with peripheral autoimmune manifestations.</td>
                        </tr>
                        <tr>
                            <td><strong>immunological_findings</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>autoantibodies_present</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>timing_relative_to_thymoma</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>effect_of_thymectomy</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>thymic_structure_abnormalities</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>t_cell_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>comparison_with_without_autoimmunity</strong></td>
                            <td>False</td>
                        </tr>
                        <tr>
                            <td><strong>control_comparison</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome', 'publication_date_yy_mm': '2019-09'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Thymoma associated with autoimmune disease: 85 cases and literature review <em>(Rating: 2)</em></li>
                <li>Paraneoplastic diseases associated with thymoma <em>(Rating: 2)</em></li>
                <li>Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis <em>(Rating: 1)</em></li>
                <li>The role of T-cells in the initiation of autoantibody response in thymoma patients <em>(Rating: 1)</em></li>
                <li>Immunology of paraneoplastic syndromes: overview <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>